The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

OncoGenex Pharmaceuticals Inc

Nasdaq: OGXI
Last

(U.S.) $0.98

Today's change0.00 0.00%
Updated April 29 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

OncoGenex Pharmaceuticals Inc

Nasdaq: OGXI
Last

(U.S.) $0.98

Today's change0.00 0.00%
Updated April 29 3:59 PM -4GMT. Delayed by at least 15 minutes.

OncoGenex Pharmaceuticals Inc closed at (U.S.)$0.98.

Over the last five days, shares have gained 13.37%, but are down 19.42% for the last year to date. Shares have underperformed the S&P 500 by 49.52% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $0.98
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.80 / (U.S.) $1.27
  • YTD % change-19.42%
  • Volume0
  • Average volume (10-day)1,742,391
  • Average volume (1-month)708,267
  • Average volume (3-month)421,459
  • 52-week range(U.S.) $0.46 to (U.S.) $4.10
  • Beta1.82
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.67
Updated April 29 3:59 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6741
Total other revenue--------
Total revenue6741
Gross profit--------
Total cost of revenue--------
Total operating expense1011106
Selling / general / administrative3333
Research & development7874
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-3-5-6-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-5-6-5
Income after tax-2-5-6-5
Income tax, total--------
Net income-2-5-6-5
Total adjustments to net income--------
Net income before extra. items-2-5-6-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-5-6-5
Inc. avail. to common incl. extra. items-2-5-6-5
Diluted net income-2-5-6-5
Dilution adjustment--------
Diluted weighted average shares30292323
Diluted EPS excluding extraordinary itemsvalue per share-0.06-0.16-0.26-0.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.06-0.16-0.26-0.20